tiprankstipranks
Anixa Biosciences announces submission of protocol amendment for CAR-T trial
PremiumThe FlyAnixa Biosciences announces submission of protocol amendment for CAR-T trial
4M ago
Anixa Biosciences announces Phase 2 study for breast cancer vaccine
Premium
The Fly
Anixa Biosciences announces Phase 2 study for breast cancer vaccine
4M ago
Arm upgraded, Molson Coors downgraded: Wall Street’s top analyst calls
Premium
The Fly
Arm upgraded, Molson Coors downgraded: Wall Street’s top analyst calls
5M ago
Anixa Biosciences treats sixth patient in ovarian cancer CAR-T clinical trial
PremiumThe FlyAnixa Biosciences treats sixth patient in ovarian cancer CAR-T clinical trial
7M ago
Anixa Biosciences price target lowered to $7 from $12 at H.C. Wainwright
Premium
The Fly
Anixa Biosciences price target lowered to $7 from $12 at H.C. Wainwright
7M ago
Anixa Biosciences begins treating fifth patient in ovarian cancer CAR-T trial
Premium
The Fly
Anixa Biosciences begins treating fifth patient in ovarian cancer CAR-T trial
8M ago
Anixa Biosciences begins dosing in second cohort of ovarian cancer CAR-T trial
PremiumThe FlyAnixa Biosciences begins dosing in second cohort of ovarian cancer CAR-T trial
11M ago
Anixa Biosciences granted ovarian cancer vaccine technology patent in Japan
Premium
The Fly
Anixa Biosciences granted ovarian cancer vaccine technology patent in Japan
12M ago
Meet Anixa Biosciences: Fly exclusive interview with CEO Amit Kumar
Premium
The Fly
Meet Anixa Biosciences: Fly exclusive interview with CEO Amit Kumar
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100